NEWARK, N.J., Feb. 16, 2011 /PRNewswire/ -- OHK Medical Devices, Inc. announced today that it has selected Henry Schein Medical, the U.S. physician business of Henry Schein Inc. (Nasdaq: HSIC), the largest distributor of health care products and services to office-based dental, medical and veterinary practitioners, as the exclusive distributor of HemaClear® for the U.S. alternate care market. HemaClear is the first and only surgical tourniquet single-use device that exsanguinates, occludes, and provides a clearer surgical field.
"HemaClear is delighted to be partnering with a company that has such an excellent reputation for bringing its customers the highest quality and most innovative products on the market," said Oren Gavriely, Chief Executive Officer, OHK Medical Devices. "We are very much looking forward to bringing this new, revolutionary standard of care to Henry Schein customers around the country."
An exsanguination device that prepares any limb for surgery in less than 12 seconds, HemaClear provides a larger, dryer, and clearer surgical field, thereby providing the surgeon with a better view of anatomical structures. Its ease of use and simplicity saves valuable operating room time. HemaClear has been proven worldwide in over 180,000 surgical cases.
"Henry Schein Medical is pleased to exclusively offer HemaClear as part of our ongoing commitment to help drive the success of our customers' practices and enable them to provide the highest quality care," said Dave McKinley, President of Henry Schein Medical. "This innovative new technology is simple, sterile, safe, cost-effective, and ultimately provides more successful surgical outcomes, especially for our customers that practice in ambulatory surgical settings and perform office-based procedures."
Manufactured by OHK Medical Devices, Inc., hea
|SOURCE OHK Medical Devices, Inc.|
Copyright©2010 PR Newswire.
All rights reserved